Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 4
1981 8
1982 3
1983 5
1984 1
1985 6
1986 8
1987 3
1988 8
1989 8
1990 21
1991 30
1992 19
1993 14
1994 21
1995 25
1996 33
1997 41
1998 38
1999 46
2000 43
2001 65
2002 73
2003 88
2004 105
2005 152
2006 178
2007 176
2008 249
2009 278
2010 330
2011 422
2012 479
2013 555
2014 642
2015 667
2016 774
2017 775
2018 862
2019 1074
2020 1209
2021 1447
2022 1646
2023 1603
2024 1850
2025 2169
2026 393

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,744 results

Results by year

Filters applied: . Clear all
Page 1
Erythropoietin receptor on cDC1s dictates immune tolerance.
Zhang X, McGinnis CS, Yu G, Chen S, Zheng P, Schürch CM, Hiam-Galvez KJ, Reticker-Flynn NE, Guo W, Yao W, Qiu J, Muselman A, Linde IL, Hickey JW, Yan H, Tran VM, Qiu W, Brichart-Vernos D, Hirai T, Yu B, An X, Xiao Y, Paidassi H, Scharschmidt TC, Angelo M, Sheppard D, Chi H, Satpathy AT, Way SS, Malissen B, Strober S, Engleman EG. Zhang X, et al. Among authors: yan h. Nature. 2026 Feb;650(8101):470-480. doi: 10.1038/s41586-025-09824-z. Epub 2025 Dec 10. Nature. 2026. PMID: 41372415
Reply.
Yan H. Yan H. J Hand Surg Eur Vol. 2026 Feb;51(2):ArticleFirstPage-ArticleLastPage. doi: 10.1177/17531934251378922#sub1-17531934251378922. Epub 2025 Dec 7. J Hand Surg Eur Vol. 2026. PMID: 41355157 No abstract available.
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Zeng L, Ruan Z, Yan H, Qin H, Zeng Z, Zou C, Huang Z, Jiang W, Dai J, Xu S, Song L, Chen Y, Zhang Y, Zeng F, Wei S, Chen S, Liu L, Xiong Y, Wang Z, Deng J, Zhang X, Sun Y, Yang D, Zhou C, Yang H, Li Y, Deng L, Xu Q, Fang C, Chen X, Wang J, Li T, Zhang G, Zhou H, Yang N, Zhang Y. Zeng L, et al. Among authors: yan h. Nat Commun. 2025 Dec 15;17(1):567. doi: 10.1038/s41467-025-67262-x. Nat Commun. 2025. PMID: 41398162 Free PMC article. Clinical Trial.
16,744 results
You have reached the last available page of results. Please see the User Guide for more information.